VIM and neoplasm: In conclusion, in this pilot study, we have shown that measurement of EMT markers (E-cadherin, vimentin, claudin-1, and ZEB1) as well tumor-suppressive miR-205 allows for robust retrospective discrimination of localized ESD-resected and regional surgically resected samples.